Skip to main content
. 2020 Dec 2;15(12):e0242559. doi: 10.1371/journal.pone.0242559

Fig 2. Comparison of total B and plasma B cells between IHCs and healthy control groups at baseline.

Fig 2

(A) Comparison of total B cells subsets between IHCs (n = 44) and healthy controls (n = 12) at baseline. (B) Comparison of plasma B cells subsets between IHCs (n = 44) and healthy controls (n = 12) at baseline.